Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04827680 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of the Safety and Performance of FRF for the Treatment and Reduction of Acne Scarring
A NA study, sponsored by Venus Concept.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT04827680 is a NA study that has completed, run by Venus Concept. The registered enrollment target is 20 participants.
The verdict
NCT04827680, a NA study, has completed, sponsored by Venus Concept.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Prospective, single centre, evaluator-blind study of the safety and performance of fractional radiofrequency (RF) for the treatment and reduction of acne scarring. The study will evaluate the progress of 20 subjects requesting treatment of acne scarring. The study will involve three treatments on both sides of the face with 3-5 week intervals between each treatment. Subjects will be followed at 6 and 12 weeks after their last treatment. Analysis will be performed on all subjects who receive at least one treatment.
Interventions
- DEVICE Venus Viva MD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-05-01 |
| Est. Completion | 2022-06-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04827680
The ClinicalTrials.gov registry entry for NCT04827680 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Venus Concept, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Venus Viva MD is the first listed.
NCT04827680 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04827680 about?
NCT04827680 is a clinical study titled "Clinical Evaluation of the Safety and Performance of FRF for the Treatment and Reduction of Acne Scarring". Prospective, single centre, evaluator-blind study of the safety and performance of fractional radiofrequency (RF) for the treatment and reduction of acne scarring. The study will evaluate the progress of 20 subjects requesting treatment of acne scarring. The study will involve three treatments on bo...
What is the current status of trial NCT04827680?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2021-05-01. Estimated completion is 2022-06-13.
What interventions are being tested in trial NCT04827680?
The interventions under investigation include: Venus Viva MD (DEVICE).
Who is sponsoring clinical trial NCT04827680?
This trial is sponsored by Venus Concept, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.